Soleo Health will Administer Primary Hyperoxaluria Type 1 Treatment at Infusion Centers Across The Country
Photo by Robina Weermeijer on Unsplash

Soleo Health will Administer Primary Hyperoxaluria Type 1 Treatment at Infusion Centers Across The Country

Soleo Health has just announced that they have been provided access to lumasiran by Alnylam Pharmaceuticals. This access will allow the company to administer the treatment to patients diagnosed with…

Continue Reading Soleo Health will Administer Primary Hyperoxaluria Type 1 Treatment at Infusion Centers Across The Country

Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines

What is Distal Renal Tubular Acidosis? Distal renal tubular acidosis (dRTA) is a rare condition which affects approximately 1 in every 100,000 people worldwide. It is caused by a build up…

Continue Reading Study Shows Distal Renal Tubular Acidosis Patient Outcomes Vary Across Country Lines